Ngā hua rapu kaituhi :: APM

1

The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma mā Frank M. Balis, Christine M. Busch, Ami V. Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S. Irwin, Elizabeth Fox

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future mā Wayne H. Liang, Sara M. Federico, Wendy B. London, Arlene Naranjo, Meredith S. Irwin, Samuel L. Volchenboum, Susan L. Cohn

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Children's Oncology Group's 2023 blueprint for research: Neuroblastoma mā Rochelle Bagatell, Steven G. DuBois, Arlene Naranjo, J. S. Van Belle, Kelly C. Goldsmith, Julie R. Park, Meredith S. Irwin

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

$Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials$

Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group earl... mā Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2 mā James I. Geller, Peter F. Ehrlich, Nicholas G. Cost, Geetika Khanna, Elizabeth A. Mullen, Eric J. Gratias, Arlene Naranjo, Jeffrey S. Dome, Elizabeth J. Perlman

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group mā Sabah Servaes, Geetika Khanna, Arlene Naranjo, James I. Geller, Peter F. Ehrlich, Kenneth W. Gow, Elizabeth J. Perlman, Jeffrey S. Dome, Eric J. Gratias, Elizabeth A. Mullen

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study mā Julie R. Park, Jeffrey R. Scott, Clinton F. Stewart, Wendy B. London, Arlene Naranjo, Victor M. Santana, Peter J. Shaw, Susan L. Cohn, Katherine K. Matthay

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG) mā Navin Pinto, Arlene Naranjo, Emily Hibbitts, Susan G. Kreissman, Meaghan Granger, Meredith S. Irwin, Rochelle Bagatell, Wendy B. London, Emily Greengard, Julie R. Park, Steven G. DuBois

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Detection of Preoperative Wilms Tumor Rupture with CT: A Report from the Children’s Oncology Group mā Geetika Khanna, Arlene Naranjo, Fredric A. Hoffer, Elizabeth A. Mullen, James I. Geller, Eric J. Gratias, Peter F. Ehrlich, Elizabeth J. Perlman, Nancy Rosen, Paul E. Grundy, Jeffrey S. Dome

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomis... mā Pedro A. de Alarcón, Katherine K. Matthay, Wendy B. London, Arlene Naranjo, Sheena C. Tenney, Jessica A. Panzer, Michael D. Hogarty, Julie R. Park, John M. Maris, Susan L. Cohn

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma mā Kira Bona, Yimei Li, Lena E. Winestone, Kelly Getz, Yuan‐Shung Huang, Brian T. Fisher, Ami V. Desai, Troy Richardson, Matt Hall, Arlene Naranjo, Tara O. Henderson, Richard Aplenc, Rochelle Bagatell

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants mā Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Robert C. Shamberger

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group mā Gregory A. Yanik, Marguerite T. Parisi, Barry L. Shulkin, Arlene Naranjo, Susan G. Kreissman, Wendy B. London, Judith G. Villablanca, John M. Maris, Julie R. Park, Susan L. Cohn, Patrick McGrady, Katherine K. Matthay

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531 mā Clare J. Twist, Arlene Naranjo, Mary Lou Schmidt, Sheena C. Tenney, Susan L. Cohn, Holly J. Meany, Peter Mattei, E. Stanton Adkins, Hiroyuki Shimada, Wendy B. London, Julie R. Park, Katherine K. Matthay, John M. Maris

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project mā Elizabeth Sokol, Ami V. Desai, Mark A. Applebaum, Dominique Valteau‐Couanet, Julie R. Park, Andrew D.J. Pearson, Gudrun Schleiermacher, Meredith S. Irwin, Michael D. Hogarty, Arlene Naranjo, Samuel L. Volchenboum, Susan L. Cohn, Wendy B. London

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Children's Oncology Group's 2013 blueprint for research: Renal tumors mā Jeffrey S. Dome, Conrad V. Fernandez, Elizabeth A. Mullen, John A. Kalapurakal, James I. Geller, Vicki Huff, Eric J. Gratias, David Dix, Peter F. Ehrlich, Geetika Khanna, Marcio H. Malogolowkin, James R. Anderson, Arlene Naranjo, Elizabeth J. Perlman

I whakaputaina 2012

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG mā Chizuko Okamatsu, Wendy B. London, Arlene Naranjo, Michael D. Hogarty, Julie M. Gastier‐Foster, A. Thomas Look, Michael P. LaQuaglia, John M. Maris, Susan L. Cohn, Katherine K. Matthay, Robert C. Seeger, Tsutomu Saji, Hiroyuki Shimada

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 mā Alix E. Seif, Arlene Naranjo, David L. Baker, Nancy Bunin, Morris Kletzel, C. Kretschmar, John M. Maris, Patrick McGrady, Daniel von Allmen, Susan L. Cohn, Wendy B. London, J R Park, Lisa Diller, Stephan A. Grupp

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group mā Kevin Campbell, Julie M. Gastier‐Foster, Meegan Mann, Arlene Naranjo, Collin Van Ryn, Rochelle Bagatell, Katherine K. Matthay, Wendy B. London, Meredith S. Irwin, Hiroyuki Shimada, Meaghan Granger, Michael D. Hogarty, Julie R. Park, Steven G. DuBois

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma mā Puja J. Umaretiya, Arlene Naranjo, Fan F. Zhang, Julie R. Park, Brian Weiss, Meaghan Granger, Ami V. Desai, M. Fevzi Özkaynak, Alice L. Yu, Rahela Aziz‐Bose, Sandi L. Pruitt, Steven G. DuBois, Rochelle Bagatell, Kira Bona

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: